EPH57 The Market Dynamics of GP IIb/IIIa Inhibitors in Germany: A Closer Look at Eptifibatide and Aggrastat
Dec 1, 2023, 00:00 AM
10.1016/j.jval.2023.09.1099
https://www.valueinhealthjournal.com/article/S1098-3015(23)04229-8/fulltext
Section Title :
Section Order :
10588
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)04229-8&doi=10.1016/j.jval.2023.09.1099